AI brief of an SEC Form 8-K · Adient (ADNT)

Adient Q3 sales rise to $3.93 billion; GAAP EPS falls to $0.32

Mixed Impact 3 of 5 earnings Written later

Adient reported third-quarter fiscal 2026 results for the quarter ended June 30, 2026, with net sales of $3,929 million, up from $3,741 million a year earlier. Net income attributable to Adient fell to $25 million, or $0.32 per diluted share, from $36 million, or $0.43, while adjusted diluted EPS rose to $0.48 from $0.45. The filing contains no updated guidance, and shareholders get a mixed picture: higher sales and adjusted EPS alongside lower GAAP earnings.

Key points

  • Net sales were $3,929 million versus $3,741 million a year earlier.
  • Diluted EPS was $0.32 versus $0.43; adjusted diluted EPS was $0.48 versus $0.45.
  • Adjusted EBITDA was $225 million versus $226 million, with an adjusted EBITDA margin of 5.7% versus 6.0%.
  • Share repurchases were $30 million in the quarter, down from $50 million, and shares outstanding at period end were 77.1 million versus 81.2 million.

The filing

CompanyAdient (ADNT)
Form8-K, current report
Filed with the SECAug 5, 2026, 6:54 AM ET
Accession number0001670541-26-000090

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.